THE DRUG DOCKET

Ventec recalls ventilators in Class I action over a connector that can reboot them

The FDA logged a Class I recall of Ventec's VOCSN, V+Pro, VC and V*Home ventilators on 28 October, citing an internal cable connector that can detach, rebooting the device and interrupting breathing support.

The Food and Drug Administration has recorded a Class I recall of ventilators made by Ventec Life Systems, after the company identified an internal connector that can come loose and interrupt the breathing support the machines provide. The agency logged the action in its enforcement database on 28 October 2026 and assigned its most serious recall classification — the category used where a defect could cause serious injury or death [s1].

What is affected

The recall sweeps across Ventec's ventilator range rather than a single model. It spans at least ten enforcement records covering the firm's VOCSN, V+Pro, VC and VHome families, including domestic and Japan-market versions [s1][s2]. Several of the records are large: the V+Pro line accounts for 39,568 units under recall number Z-0129-2027, the V+Pro Emergency model for 30,120 units, and the VHome home-use ventilator for 25,112 units under Z-0133-2027 [s1][s2]. All serial numbers of the named models are affected, and the devices were distributed across the United States including Puerto Rico [s1][s2]. Ventec, based in Bothell, Washington, began the recall itself on 17 September 2026, making it a voluntary, firm-initiated action that the agency records as ongoing [s1].

Why the fault matters

The enforcement record describes the problem precisely: the ventilator's internal flow transducer cable connector may disconnect from the internal board [s1]. The flow transducer is how the machine measures the air it is moving; the record notes that a disconnection can cause the system to reboot and interrupt ventilation therapy [s1].

For a ventilator, an unexpected reboot is not a minor glitch. These machines breathe for patients who cannot adequately breathe for themselves, and even a short interruption while the device restarts can be dangerous — more so for a patient who is fully dependent on support and has little reserve of their own. That is the reasoning behind the Class I label. The record documents the defect and the units involved; it does not report patient harm, and the absence of such a report is not proof that none occurred [s1].

Where these ventilators are used

Ventec's platform is unusual in combining several respiratory therapies in one unit, and its devices are used across a wide span of settings — hospital, transport, emergency and the home. The V*Home model named in the recall points to use outside clinical walls, where a device supports a patient who lives with chronic respiratory failure and may rely on it continuously [s2]. That breadth is part of why a connector fault becomes a large correction: the same component sits inside machines in intensive-care units and in living rooms alike.

What it means in practice

A Class I recall of a life-support device sets an urgent, practical task for the clinicians, respiratory therapists, home-care providers and families who operate these ventilators. The core steps are to identify whether a device in use is among the named models, to follow Ventec's correction instructions, and — critically for life-support equipment — to keep a backup means of ventilation and a plan in place should a device reboot mid-use [s1].

Because the recall reaches the home-use V*Home as well as professional models, some of the people affected are patients and caregivers rather than hospital staff [s2]. For them the reasonable action is not to stop a prescribed therapy on their own, but to contact the device supplier and their clinical team promptly to confirm whether their unit is affected and what Ventec advises [s1][s2]. Stopping ventilation support without a plan would itself be hazardous.

What to watch

Two things. First, whether more of Ventec's records are added or the counts revised: enforcement entries are updated as the firm and the agency work through affected serial numbers, and the per-model figures in the records are the authoritative detail [s1][s2]. Second, the fix itself — a Class I action turns on how quickly and reliably the manufacturer's correction reaches devices that are, in many cases, in continuous use.

Red flags: anyone relying on a home ventilator who sees the device restart unexpectedly, or who develops breathlessness, confusion, blue-tinged lips or distress while supported, should treat it as an emergency, switch to any backup support available and call for urgent help. This article describes an FDA enforcement action and is not medical advice. Questions about a specific ventilator or breathing-support plan are for the treating clinicians and the equipment supplier.

Sources

  1. FDA Enforcement Report Z-0129-2027: Ventec V+Pro ventilator (Ventec Life Systems) — U.S. Food and Drug Administration (openFDA device/enforcement API) , October 28, 2026
  2. FDA Enforcement Report Z-0133-2027: Ventec V*Home ventilator (Ventec Life Systems) — U.S. Food and Drug Administration (openFDA device/enforcement API) , October 28, 2026
Related coverage